Home › Companies › HAEMONETICS CORP. › 2023-2024

HAEMONETICS CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed August 7, 2023 (Item 5.07 on EDGAR). Page generated October 14, 2026.

12Reported items
339Asset managers
5,639Fund votes
August 4, 2023Meeting date

Results at a glance

Meeting of August 4, 2023: 11 items on HAEMONETICS CORP.’s Form 8-K, filed August 7, 2023: 3 approved · 8 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by HAEMONETICS CORP.

These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 7, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HAEMONETICS CORP. — official shareholder meeting results, meeting held August 4, 2023
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Christopher A. Simon	46,433,691	--	--	328,714	1,685,092	99.2%	Not verified	—
Elect Director: Robert E. Abernathy	45,088,242	--	--	1,674,163	1,685,092	96%	Not verified	—
Elect Director: Michael J. Coyle	46,424,781	--	--	337,624	1,685,092	99.2%	Not verified	—
Elect Director: Charles J. Dockendorff	45,030,197	--	--	1,732,208	1,685,092	96%	Not verified	—
Elect Director: Lloyd E. Johnson	42,123,209	--	--	4,639,196	1,685,092	90%	Not verified	—
Elect Director: Mark W. Kroll	46,097,712	--	--	664,693	1,685,092	99%	Not verified	—
Elect Director: Claire Pomeroy	46,378,877	--	--	383,528	1,685,092	99.1%	Not verified	—
Elect Director: Ellen M. Zane	39,666,573	--	--	7,095,832	1,685,092	85%	Not verified	—
2. The compensation of the Company's named executive officers based upon the following votes	44,958,577	1,776,928	26,900	--	1,685,092	96%	Approved	—
4. A proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes	45,678,506	1,058,808	25,091	--	1,685,092	98%	Approved	—
5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes	47,679,417	748,049	20,031	--	--	98%	Approved	—

Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on August 7, 2023 — read the filing on EDGAR.

How asset managers voted at the HAEMONETICS CORP. 2023-2024 meeting

Each item below shows how the 339 asset managers that disclosed a HAEMONETICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of HAEMONETICS CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Charles J. Dockendorff

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 45,030,197WITHHELD: 1,732,208

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Charles J. Dockendorff

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 45,030,197 for, 1,732,208 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 30,550,918 for, 373,978 withheld.

FOR

FOR: 30,550,918WITHHOLD: 373,978

Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	0	283,956	Withhold
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

2. Elect Director: Christopher A. Simon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 46,433,691WITHHELD: 328,714

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Christopher A. Simon

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 46,433,691 for, 328,714 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 30,908,346 for, 16,550 withheld.

FOR

FOR: 30,908,346WITHHOLD: 16,550

Largest asset managers voting on “Election of Directors: Christopher A. Simon” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

3. Elect Director: Claire Pomeroy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 46,378,877WITHHELD: 383,528

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Claire Pomeroy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 46,378,877 for, 383,528 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 30,904,031 for, 20,865 withheld.

FOR

FOR: 30,904,031WITHHOLD: 20,865

Largest asset managers voting on “Election of Directors: Claire Pomeroy” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

4. Elect Director: Ellen M. Zane

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD

FOR: 39,666,573WITHHELD: 7,095,832

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Ellen M. Zane

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 39,666,573 for, 7,095,832 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 28,226,480 for, 2,695,105 withheld, 3,311 abstained.

FOR

FOR: 28,226,480ABSTAIN: 3,311WITHHOLD: 2,695,105

Largest asset managers voting on “Election of Directors: Ellen M. Zane” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	5,231,650	970,721	Mixed
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	45,766	334,335	Mixed
State Street	0	355,759	Withhold
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	0	292,855	Withhold
BOSTON TRUST WALDEN FUNDS	0	283,956	Withhold
Equitable	222,189	0	For
John Hancock	68,199	135,300	Mixed
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

5. Elect Director: Lloyd E. Johnson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 42,123,209WITHHELD: 4,639,196

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Lloyd E. Johnson

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 42,123,209 for, 4,639,196 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 28,962,846 for, 1,962,050 withheld.

FOR

FOR: 28,962,846WITHHOLD: 1,962,050

Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	5,231,650	970,721	Mixed
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	45,766	334,335	Mixed
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	0	283,956	Withhold
Equitable	222,189	0	For
John Hancock	68,199	135,300	Mixed
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

6. Elect Director: Mark W. Kroll

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 46,097,712WITHHELD: 664,693

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Mark W. Kroll

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,097,712 for, 664,693 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 30,900,710 for, 24,186 withheld.

FOR

FOR: 30,900,710WITHHOLD: 24,186

Largest asset managers voting on “Election of Directors: Mark W. Kroll” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

7. Elect Director: Michael J. Coyle

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 46,424,781WITHHELD: 337,624

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Michael J. Coyle

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 46,424,781 for, 337,624 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 114 asset managers below reported 30,908,346 for, 16,550 withheld.

FOR

FOR: 30,908,346WITHHOLD: 16,550

Largest asset managers voting on “Election of Directors: Michael J. Coyle” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

8. Elect Director: Robert E. Abernathy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 45,088,242WITHHELD: 1,674,163

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: Election of Directors: Robert E. Abernathy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 45,088,242 for, 1,674,163 withheld, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 114 asset managers below reported 30,574,892 for, 346,693 withheld, 3,311 abstained.

FOR

FOR: 30,574,892ABSTAIN: 3,311WITHHOLD: 346,693

Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	0	283,956	Withhold
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

9. 4. A proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive…

Official resultCOMPENSATIONReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 45,678,506AGAINST: 1,058,808

Details: description as filed, official tally, votes by 115 asset managers

Description as filed by funds: To approve an amendment and restatement of the Haemonetics Corporation 2019 Long term Incentive Compensation Plan.

HAEMONETICS CORP.’s own tally for this item (“4. A proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes”): 45,678,506 for, 1,058,808 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved a proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of HAEMONETICS CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “AMEND OMNIBUS STOCK PLAN” (3 managers, 34,384 for).

The 115 asset managers below reported 30,805,681 for, 69,251 against, 16,550 abstained.

FOR

FOR: 30,805,681AGAINST: 69,251ABSTAIN: 16,550

Largest asset managers voting on “To approve an amendment and restatement of the Haemonetics Corporation 2019 Long term Incentive Compensation P” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 115 asset managers. See all 115 in the interactive database.

10. 2. The compensation of the Company's named executive officers based upon the following votes

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%

FOR: 44,958,577AGAINST: 1,776,928

Details: description as filed, official tally, votes by 324 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

HAEMONETICS CORP.’s own tally for this item (“2. The compensation of the Company's named executive officers based upon the following votes”): 44,958,577 for, 1,776,928 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 112 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	6,202,371	0	0	For
Capital Group	4,082,955	0	0	For
BlackRock	3,506,360	0	0	For
Fidelity	2,614,428	0	0	For
AMCAP FUND	2,573,462	0	0	For
Neuberger Berman	2,238,280	0	0	For
Franklin Custodian Funds	937,264	0	0	For
Royce	823,657	0	0	For
Invesco	622,655	0	0	For
Dimensional	524,910	0	0	For
Charles Schwab	503,192	0	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	0	For
T. Rowe Price	385,042	0	0	For
Hartford	380,101	0	0	For
State Street	355,759	0	0	For
Brighthouse	293,035	0	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	0	For
Columbia Threadneedle	0	292,855	0	Against
BOSTON TRUST WALDEN FUNDS	283,956	0	0	For
Equitable	222,189	0	0	For
John Hancock	203,499	0	0	For
Allspring	200,275	0	0	For
HARBOR FUNDS	200,110	0	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	0	For
Victory Capital	145,679	0	0	For

Fund voting reports, all 112 managers: 30,538,539 for, 368,316 against, 15,929 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 240 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Against	Vote
Capital Research Global Investors	6,687,612	0	For
Neuberger Berman	3,502,787	613	For
Wellington	2,854,967	0	For
Fidelity	1,884,758	0	For
BlackRock	1,684,934	6,768	For
State Street	1,631,985	0	For
FRANKLIN ADVISERS INC	1,490,795	0	For
Janus Henderson	1,000,000	0	For
GEODE CAPITAL MANAGEMENT, LLC	950,724	0	For
SCHRODER INVESTMENT MANAGEMENT GROUP	911,386	0	For
Invesco	679,834	0	For
MELLON INVESTMENTS Corp	651,781	0	For
Man Group plc	0	643,770	Against
T. Rowe Price	542,537	0	For
Bridgewater	519,150	0	For
Charles Schwab	503,192	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	382,805	29,974	Mixed
Fisher Asset Management, LLC	369,216	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	327,894	8,653	For
HEARTLAND ADVISORS INC	302,336	0	For
Allspring	280,787	0	For
Aristotle Capital Boston, LLC	263,728	0	For
Boston Trust Walden Co	258,835	0	For
Victory Capital	235,742	0	For
PRINCIPAL GLOBAL INVESTORS	203,434	0	For

Institutional-manager reports, all 240 managers: 32,171,969 for, 1,310,362 against, 537 not voted, 77,966 1 year. Showing the 25 largest; see all in the interactive database.

11. To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive…

No official match Fund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

98% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR

Details: description as filed, votes by 306 asset managers

Description as filed by funds: To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 111 asset managers voting on “To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named exec” at HAEMONETICS CORP., 2023-2024
Asset manager	Abstain	Vote
Vanguard	0	--
Capital Group	0	--
BlackRock	0	--
Fidelity	0	--
AMCAP FUND	0	--
Neuberger Berman	0	--
Franklin Custodian Funds	0	--
Royce	0	--
Invesco	0	--
Dimensional	0	--
Charles Schwab	0	--
FRANKLIN STRATEGIC SERIES	0	--
T. Rowe Price	0	--
Hartford	0	--
State Street	0	--
Brighthouse	15,929	Abstain
HEARTLAND GROUP INC	0	--
Columbia Threadneedle	0	--
BOSTON TRUST WALDEN FUNDS	0	--
Equitable	0	--
John Hancock	0	--
Allspring	0	--
HARBOR FUNDS	0	--
SCHWARTZ INVESTMENT TRUST	0	--
Victory Capital	0	--

Fund voting reports, all 111 managers: 3,311 for, 15,929 abstained, 30,123,691 1 year, 577,353 3 year, 159,000 2 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 223 asset managers voting on “To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named exec” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Capital Research Global Investors	0	0	0	0	--
Neuberger Berman	0	0	0	0	--
Wellington	0	0	0	0	--
Fidelity	0	0	0	0	--
BlackRock	0	0	0	0	--
State Street	0	0	0	0	--
FRANKLIN ADVISERS INC	0	0	0	0	--
Janus Henderson	0	0	0	0	--
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	--
SCHRODER INVESTMENT MANAGEMENT GROUP	0	0	0	0	--
Invesco	0	0	0	0	--
MELLON INVESTMENTS Corp	0	0	0	0	--
Man Group plc	0	0	0	0	--
T. Rowe Price	0	0	0	0	--
Bridgewater	0	0	0	0	--
Charles Schwab	0	0	0	0	Not Voted
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	0	0	0	0	--
Fisher Asset Management, LLC	0	0	0	0	--
WESTFIELD CAPITAL MANAGEMENT CO LP	0	0	0	0	--
HEARTLAND ADVISORS INC	0	0	0	0	--
Allspring	0	0	0	0	--
Aristotle Capital Boston, LLC	0	0	0	0	--
Boston Trust Walden Co	0	0	0	0	--
Victory Capital	0	0	0	0	--
PRINCIPAL GLOBAL INVESTORS	0	0	0	0	--

Institutional-manager reports, all 223 managers: 81,042 for, 1,798 against, 537 not voted, 33,095,241 1 year, 112,079 3 year. Showing the 25 largest; see all in the interactive database.

12. 5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 47,679,417AGAINST: 748,049

Details: description as filed, official tally, votes by 114 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 30, 2024.

HAEMONETICS CORP.’s own tally for this item (“5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes”): 47,679,417 for, 748,049 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 30,900,952 for, 8,015 against, 15,929 abstained.

FOR

FOR: 30,900,952AGAINST: 8,015ABSTAIN: 15,929

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at HAEMONETICS CORP., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	6,202,371	0	For
Capital Group	4,082,955	0	For
BlackRock	3,506,360	0	For
Fidelity	2,614,428	0	For
AMCAP FUND	2,573,462	0	For
Neuberger Berman	2,238,280	0	For
Franklin Custodian Funds	937,264	0	For
Royce	823,657	0	For
Invesco	622,655	0	For
Dimensional	524,910	0	For
Charles Schwab	503,192	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
T. Rowe Price	385,042	0	For
Hartford	380,101	0	For
State Street	355,759	0	For
Brighthouse	293,035	15,929	Mixed
HEARTLAND GROUP INC	295,000	0	For
Columbia Threadneedle	292,855	0	For
BOSTON TRUST WALDEN FUNDS	283,956	0	For
Equitable	222,189	0	For
John Hancock	203,499	0	For
Allspring	200,275	0	For
HARBOR FUNDS	200,110	0	For
SCHWARTZ INVESTMENT TRUST	159,000	0	For
Victory Capital	145,679	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

Not shown here: this season’s fund filings also report 11 items from the meeting of July 25, 2024, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest HAEMONETICS CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,705,779 shares outstanding at the time of that meeting.

Fund voting reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	12.23%
2	Capital Group	8.05%
3	BlackRock	6.92%
4	Fidelity	5.16%
5	AMCAP FUND	5.08%
6	Neuberger Berman	4.41%
7	Franklin Custodian Funds	1.85%
8	Royce	1.62%
9	Invesco	1.23%
10	Dimensional	1.04%

Institutional-manager reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	Capital Research Global Investors	13.19%
2	Neuberger Berman	6.91%
3	Wellington	5.63%
4	Fidelity	3.72%
5	BlackRock	3.34%
6	State Street	3.22%
7	FRANKLIN ADVISERS INC	2.94%
8	Janus Henderson	1.97%
9	GEODE CAPITAL MANAGEMENT, LLC	1.87%
10	SCHRODER INVESTMENT MANAGEMENT GROUP	1.80%

Reported HAEMONETICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

HAEMONETICS CORP. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Capital Research Global Investors	12.87%	DEF14A
BlackRock	11.87%	13F
Vanguard Group	9.53%	13F
Wellington Management	8.42%	13F
Neuberger Berman Group LLC	6.96%	DEF14A
State Street	3.61%	13F
Franklin Templeton	2.75%	13F
FMR (Fidelity)	2.40%	13F
Geode Capital	2.22%	13F
Dimensional Fund Advisors	1.82%	13F

Percentages above are of 50,705,779 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated July 1, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated July 1, 2023. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At HAEMONETICS CORP.'s shareholder meeting held August 4, 2023, in the 2023-2024 proxy season, 339 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,639 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — HAEMONETICS CORP.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 7, 2023.

HAEMONETICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.